Timo Otonkoski
Impact in
-
- Diabetes Management and Research
- Hyperglycemia and glycemic control in critically ill and hospitalized patients
- Genetics top 0.2%
- Diabetes and associated disorders
Papers in
- Surgery 117
- Pancreatic function and diabetes 112
-
- Pluripotent Stem Cells Research 44
- CRISPR and Genetic Engineering 32
- Metabolism, Diabetes, and Cancer 22
- Epigenetics and DNA Methylation 11
- Co-authors
- Jarkko Ustinov (31 shared papers)Alberto Hayek (14 shared papers)Jaan Palgi (16 shared papers)Ras Trokovic (24 shared papers)Hanna Huopio (16 shared papers)Martin I. Mally (9 shared papers)Diego Balboa (29 shared papers)Karolina Lundin (13 shared papers)
- Journals
- Diabetes (25 papers)Diabetologia (20 papers)The Journal of Clinical Endocrinology & Metabolism (10 papers)Stem Cell Research (7 papers)Stem Cell Reports (7 papers)
- Partner nations
- FinlandSwedenUnited States
In The Last Decade
Timo Otonkoski
180 papers receiving 9.6k citations
Timo Otonkoski's Hit Papers
Peers
Comparison fields: 5 of 131
- Endocrinology, Diabetes and Metabolism 3.0k
- Genetics 3.3k
- Surgery 4.9k
- Molecular Biology 4.9k
- Aging 89
Countries citing papers authored by Timo Otonkoski
This map shows the geographic impact of Timo Otonkoski's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Timo Otonkoski with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Timo Otonkoski more than expected).
Fields of papers citing papers by Timo Otonkoski
This network shows the impact of papers produced by Timo Otonkoski. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Timo Otonkoski. The network helps show where Timo Otonkoski may publish in the future.
Co-authors
The 25 scholars most cited alongside Timo Otonkoski, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 185 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Copy number variation and selection during reprogramming to pluripotency Hit paper breakdown → | 2011 | 693 |
| 2 | 2010 | 243 | |
| 3 | 2012 | 239 | |
| 4 | 1993 | 214 | |
| 5 | 2004 | 211 | |
| 6 | 2000 | 207 | |
| 7 | 2003 | 202 | |
| 8 | 2005 | 190 | |
| 9 | 2006 | 190 | |
| 10 | 2006 | 185 | |
| 11 | 2016 | 176 | |
| 12 | 2000 | 165 | |
| 13 | 2014 | 162 | |
| 14 | 2007 | 158 | |
| 15 | 2000 | 156 | |
| 16 | 2015 | 147 | |
| 17 | 2013 | 147 | |
| 18 | 2004 | 147 | |
| 19 | 1996 | 141 | |
| 20 | 2003 | 135 |
About Timo Otonkoski
Timo Otonkoski is a scholar working on Surgery, Molecular Biology, Genetics, Endocrinology, Diabetes and Metabolism and Oncology, having authored 185 papers that have together received 9.8k indexed citations. Recurring topics across this work include Pancreatic function and diabetes (112 papers), Diabetes and associated disorders (45 papers), Pluripotent Stem Cells Research (44 papers), CRISPR and Genetic Engineering (32 papers), Hyperglycemia and glycemic control in critically ill and hospitalized patients (32 papers), Diabetes Management and Research (31 papers), Metabolism, Diabetes, and Cancer (22 papers) and Epigenetics and DNA Methylation (11 papers). The work is most often cited by research in Endocrinology, Diabetes and Metabolism (3.0k citations), Genetics (3.3k citations), Surgery (4.9k citations), Molecular Biology (4.9k citations) and Aging (89 citations). Timo Otonkoski has collaborated with scholars based in Finland, Sweden and United States. Frequent co-authors include Jarkko Ustinov, Alberto Hayek, Jaan Palgi, Ras Trokovic, Hanna Huopio, Martin I. Mally, Diego Balboa, Karolina Lundin, Olle Korsgren and Gillian M. Beattie. Their work appears in journals such as Diabetes, Diabetologia, The Journal of Clinical Endocrinology & Metabolism, Stem Cell Research and Stem Cell Reports.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.